Antibody Discovery Market

Antibody Discovery Market (Antibody Type: Monoclonal, Polyclonal, and Others; and Service: Phage Display, Hybridoma, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034

Antibody Discovery Market Outlook 2034

  • The global industry was valued at US$ 1.6 Bn in 2023
  • It is expected to grow at a CAGR of 10.1% from 2024 to 2034 and reach US$ 4.8 Bn by the end of 2034

Analyst Viewpoint

Growing advancements in antibody engineering are responsible for expansion of antibody discovery market size. The biopharmaceutical industry that has been focusing on biologics is investing heavily in antibody research services. Rise in partnerships between academic institutions and industry players enable sharing of resources, thereby accelerating the discovery of antibodies.

The key players in antibody discovery market are collaborating with the high-tech companies in order to use generative AI to produce foundation models for development of therapeutic antibodies.

They are working toward combining clinical developments and data science expertise to integrate ML technologies with high-speed wet lab. The desired outcome is high-quality antibodies for multiple therapeutic targets.

Antibody Discovery Market Overview

Antibodies are evolving into one of the versatile classes of biopharmaceuticals, which are undergoing notable advancements with respect to their engineering, discovery methods, and diversification of formats. As per the National Institute of Health, 162 antibody therapies are approved by atleast one regulatory agency as of June 30, 2022.

The complexities associated with monoclonal antibodies discovery are prompting various organizations to utilize and license specialized antibody technologies and platforms.

However, discovering antibodies involves various complexities that may affect the manufacturing capacity and efficiency of antibody therapeutics. For instance, bacterial systems are likely to synthesize inactive proteins, which can result in formation of inclusion bodies.

Moreover, bacteria can do away with signal peptides but not the preproteins such as native coagulation growth factors that can’t be broken. These factors may restrain the antibody discovery market during the forecast period.

Attribute Detail
Market Drivers
  • Increase in Advancements in Antibody Engineering
  • Rise in Frequency of Collaborations of Pharmaceutical Companies with Academic Institutions

Rise in Advancements in Antibody Engineering Propelling Antibody Discovery Industry Demand

Antibody engineering is one of the specialized fields that emphasizes modification of antibodies in order to improve their therapeutic properties. The benefits of antibody engineering include personalization of therapeutic indications and the targeted effects related to this personalization.

The antibody engineering techniques used to produce antibody fragments include single B-cell technology, phage display, hybridoma technology, and also transgenic animals.

The latest advancements include Wacker’s ESETEC secretion technology for obtaining expression post secretion of antibody fragments (Fab) exceeding 4.0 g/L and scFv that exceeds 3.5 g/L into fermentation broth.

Pelican Expression Technology Platform and pOP prokaryotic expression vector are the other platforms meant to create an ample of antibody fragments.

Advantages of antibody engineering such as proper folding of antibodies coupled with essential modifications like glycosylation is one of the major aspects pertaining to discovery of antibodies.

The advancements mentioned above provide a better resolution of the expressions used for producing antibodies, thereby speeding up their discovery.

Need to combat targeted diseases at a faster pace is thus boosting the antibody discovery market revenue.

Increase in Frequency of Collaborations of Pharmaceutical Companies with Academic Institutions Driving Discovery of Antibodies

The key players in the global antibody discovery industry are emphasizing collaborative approach, which helps them in leveraging the manufacturing and research capabilities along with professional expertise of each other. This approach helps in reducing the overheads coupled with fast-tracking the discovery of antibodies.

Along these lines mentioned above, AstraZeneca, since July 2023, is engaged in an open-label, phase II study in collaboration with University Health Network (Toronto) with the objective of assessing efficacy of AZD2936 with respect to molecular residual disease (MRD) clearance and outcome in the patients after administering AXD2936 post definitive treatment for high-risk locoregionally advanced head and neck squamous cell carcinoma (LA-HNSCC).

In January 2023, Ono Pharmaceutical Co., Ltd. announced that it had inked an option and research collaboration agreement with Monash University in order to discover as well as develop antibodies that are targeting G protein-coupled receptors (GPCRs). The major objective was to create new therapeutics to treat inflammatory and autoimmune diseases.

Research-based collaborations are thus driving the antibody discovery market opportunities.

Regional Analysis of Antibody Discovery Adoption and Usage Patterns

Attribute Detail
Leading Region North America

As per the latest antibody discovery market analysis, North America held the largest share of monoclonal antibody discovery landscape in 2023 and the scenario is expected to persist during the forecast period.

This is attributed to advancement in infrastructure routed toward discovery of antibodies. In June 2023, AbTherx announced that it had launched Atlas Mice, its transgenic mouse-based antibody discovery platform.

Asia Pacific’s noticeable antibody discovery market growth is due to new product launch by the companies based in this region.

For instance, in June 2023, Sanyou Biopharmaceuticals introduced Sanyou Super Trillion Common Light Chain Antibody Discovery Platform that expends support to discovery of the bispecific antibody formats.

Analysis of Antibody Discovery Market Manufacturers

The companies involved in discovery of antibodies are engaged in organic as well as inorganic modes of expansion to increase their footprint.

For instance, in October 2023, F. Hoffmann-La Roche Ltd. inked a definitive agreement for acquiring Televant with the purpose of receiving manufacturing, development, and commercialization rights in Japan and the U.S. for Televant’s TL1A directed antibody called RVT-3101.

In December 2022, AbbVie Inc. strategically collaborated with HotSpot Therapeutics to license the agreement for the latter’s discovery-stage IRF5 program to treat autoimmune diseases.

Biocytogen Pharmaceuticals (Beijing) Co., Ltd., Evotec A.G., Sartorius AG, Charles River Laboratories International, Inc., Creative Biolabs, Inc., Bruker Cellular Analysis, Inc., BioDuro LLC, Aragen Life Sciences, Abzena, AbTherx, and Sanyou Biopharmaceuticals Co., Ltd. are some of the key players covered in the antibody discovery market report.

These players have been highlighted based on parameters such as company overview, business strategies, financial overview, product portfolio, and business segments.

Competitive Landscape of the Antibody Discovery Market

  • In January 2023, AbbVie Inc. entered into strategic collaboration with Immunome, Inc. with the objective of identifying up to new target-antibody pairs using the latter’s Discovery Engine.

Global Antibody Discovery Market Snapshot

Attribute Detail
Market Size in 2023 US$ 1.6 Bn
Market Forecast (Value) in 2034 US$ 4.8 Bn
Growth Rate (CAGR) 10.1%
Forecast Period 2024-2034
Historical Data Available for 2020-2022
Quantitative Units US$ Bn for Value
Market Analysis It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis.
Competition Landscape
  • Market share analysis by company (2023)
  • Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials
Format Electronic (PDF) + Excel
Market Segmentation
  • Antibody Type
    • Monoclonal
    • Polyclonal
    • Others
  • Service
    • Phage Display
    • Hybridoma
    • Others
  • End-user
    • Pharmaceutical and Biotechnology Companies
    • Research Laboratories
    • Others
Regions Covered
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
Countries Covered
  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • China
  • India
  • Japan
  • Australia & New Zealand
  • Brazil
  • Mexico
  • South Africa
  • GCC
Companies Profiled
  • Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
  • Evotec A.G.
  • Sartorius AG
  • Charles River Laboratories International, Inc.
  • Creative Biolabs, Inc.
  • Bruker Cellular Analysis, Inc.
  • BioDuro LLC
  • Aragen Life Sciences
  • Abzena
  • AbTherx
  • Sanyou Biopharmaceuticals Co., Ltd.
  • Other Prominent Players
Customization Scope Available Upon Request
Pricing Available Upon Request

Frequently Asked Questions

How big was the global antibody discovery market in 2023?

It was valued at US$ 1.6 Bn in 2023

How is the antibody discovery business expected to grow during the forecast period?

It is projected to advance at a CAGR of 10.1% from 2024 to 2034

What are the key factors driving the demand for antibody discovery?

Rise in advancements in antibody engineering and increase in frequency of collaboration of pharmaceutical companies with academic institutions

Which antibody discovery end-user segment held the largest share in 2023?

Pharmaceutical and biotechnology companies accounted for the largest share in 2023

Which region dominated the global antibody discovery landscape in 2023?

North America was the dominant region in 2023

Who are the key antibody discovery manufacturers?

Biocytogen Pharmaceuticals (Beijing) Co., Ltd., Evotec A.G., Sartorius AG, Charles River Laboratories International, Inc., Creative Biolabs, Inc., Bruker Cellular Analysis, Inc., BioDuro LLC, Aragen Life Sciences, Abzena, AbTherx, Sanyou Biopharmaceuticals Co., Ltd., and other prominent players

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Antibody Discovery Market

4. Market Overview

    4.1. Introduction

        4.1.1. Product Definition

        4.1.2. Industry Evolution/Developments

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Antibody Discovery Market Analysis and Forecast, 2020-2034

5. Key Insights

    5.1. Pipeline Analysis

    5.2. Key Product /Brand Analysis

    5.3. Key Mergers & Acquisitions

    5.4. COVID-19 Pandemic Impact on Industry

6. Global Antibody Discovery Market Analysis and Forecast, by Antibody Type

    6.1. Introduction & Definition

    6.2. Key Findings/Developments

    6.3. Market Value Forecast, by Antibody Type, 2020-2034

        6.3.1. Monoclonal

        6.3.2. Polyclonal

        6.3.3. Others

    6.4. Market Attractiveness Analysis, by Antibody Type

7. Global Antibody Discovery Market Analysis and Forecast, by Service

    7.1. Introduction & Definition

    7.2. Key Findings/Developments

    7.3. Market Value Forecast, by Service, 2020-2034

        7.3.1. Phage Display

        7.3.2. Hybridoma

        7.3.3. Others

    7.4. Market Attractiveness Analysis, by Service

8. Global Antibody Discovery Market Analysis and Forecast, by End-user

    8.1. Introduction & Definition

    8.2. Key Findings/Developments

    8.3. Market Value Forecast, by End-user, 2020-2034

        8.3.1. Pharmaceutical and Biotechnology Companies

        8.3.2. Research Laboratories

        8.3.3. Others

    8.4. Market Attractiveness Analysis, by End-user

9. Global Antibody Discovery Market Analysis and Forecast, by Region

    9.1. Introduction

    9.2. Key Findings/Developments

    9.3. Market Value Forecast, by Region, 2020-2034

        9.3.1. North America

        9.3.2. Europe

        9.3.3. Asia Pacific

        9.3.4. Latin America

        9.3.5. Middle East & Africa

    9.4. Market Attractiveness Analysis, by Region

10. North America Antibody Discovery Market Analysis and Forecast

    10.1. Introduction

    10.2. Key Findings

    10.3. Market Value Forecast, by Antibody Type, 2020-2034

        10.3.1. Monoclonal

        10.3.2. Polyclonal

        10.3.3. Others

    10.4. Market Value Forecast, by Service, 2020-2034

        10.4.1. Phage Display

        10.4.2. Hybridoma

        10.4.3. Others

    10.5. Market Value Forecast, by End-user, 2020-2034

        10.5.1. Pharmaceutical and Biotechnology Companies

        10.5.2. Research Laboratories

        10.5.3. Others

    10.6. Market Value Forecast, by Country, 2020-2034

        10.6.1. U.S.

        10.6.2. Canada

    10.7. Market Attractiveness Analysis

        10.7.1. By Antibody Type

        10.7.2. By Service

        10.7.3. By End-user

        10.7.4. By Country

11. Europe Antibody Discovery Market Analysis and Forecast

    11.1. Introduction

    11.2. Key Findings

    11.3. Market Value Forecast, by Antibody Type, 2020-2034

        11.3.1. Monoclonal

        11.3.2. Polyclonal

        11.3.3. Others

    11.4. Market Value Forecast, by Service, 2020-2034

        11.4.1. Phage Display

        11.4.2. Hybridoma

        11.4.3. Others

    11.5. Market Value Forecast, by End-user, 2020-2034

        11.5.1. Pharmaceutical and Biotechnology Companies

        11.5.2. Research Laboratories

        11.5.3. Others

    11.6. Market Value Forecast, by Country/Sub-region, 2020-2034

        11.6.1. Germany

        11.6.2. U.K.

        11.6.3. France

        11.6.4. Italy

        11.6.5. Spain

        11.6.6. Rest of Europe

    11.7. Market Attractiveness Analysis

        11.7.1. By Antibody Type

        11.7.2. By Service

        11.7.3. By End-user

        11.7.4. By Country/Sub-region

12. Asia Pacific Antibody Discovery Market Analysis and Forecast

    12.1. Introduction

    12.2. Key Findings

    12.3. Market Value Forecast, by Antibody Type, 2020-2034

        12.3.1. Monoclonal

        12.3.2. Polyclonal

        12.3.3. Others

    12.4. Market Value Forecast, by Service, 2020-2034

        12.4.1. Phage Display

        12.4.2. Hybridoma

        12.4.3. Others

    12.5. Market Value Forecast, by End-user, 2020-2034

        12.5.1. Pharmaceutical and Biotechnology Companies

        12.5.2. Research Laboratories

        12.5.3. Others

    12.6. Market Value Forecast, by Country/Sub-region, 2020-2034

        12.6.1. China

        12.6.2. Japan

        12.6.3. India

        12.6.4. Australia & New Zealand

        12.6.5. Rest of Asia Pacific

    12.7. Market Attractiveness Analysis

        12.7.1. By Antibody Type

        12.7.2. By Service

        12.7.3. By End-user

        12.7.4. By Country/Sub-region

13. Latin America Antibody Discovery Market Analysis and Forecast

    13.1. Introduction

    13.2. Key Findings

    13.3. Market Value Forecast, by Antibody Type, 2020-2034

        13.3.1. Monoclonal

        13.3.2. Polyclonal

        13.3.3. Others

    13.4. Market Value Forecast, by Service, 2020-2034

        13.4.1. Phage Display

        13.4.2. Hybridoma

        13.4.3. Others

    13.5. Market Value Forecast, by End-user, 2020-2034

        13.5.1. Pharmaceutical and Biotechnology Companies

        13.5.2. Research Laboratories

        13.5.3. Others

    13.6. Market Value Forecast, by Country/Sub-region, 2020-2034

        13.6.1. Brazil

        13.6.2. Mexico

        13.6.3. Rest of Latin America

    13.7. Market Attractiveness Analysis

        13.7.1. By Antibody Type

        13.7.2. By Service

        13.7.3. By End-user

        13.7.4. By Country/Sub-region

14. Middle East & Africa Antibody Discovery Market Analysis and Forecast

    14.1. Introduction

    14.2. Key Findings

    14.3. Market Value Forecast, by Antibody Type, 2020-2034

        14.3.1. Monoclonal

        14.3.2. Polyclonal

        14.3.3. Others

    14.4. Market Value Forecast, by Service, 2020-2034

        14.4.1. Phage Display

        14.4.2. Hybridoma

        14.4.3. Others

    14.5. Market Value Forecast, by End-user, 2020-2034

        14.5.1. Pharmaceutical and Biotechnology Companies

        14.5.2. Research Laboratories

        14.5.3. Others

    14.6. Market Value Forecast, by Country/Sub-region, 2020-2034

        14.6.1. GCC Countries

        14.6.2. South Africa

        14.6.3. Rest of Middle East & Africa

    14.7. Market Attractiveness Analysis

        14.7.1. By Antibody Type

        14.7.2. By Service

        14.7.3. By End-user

        14.7.4. By Country/Sub-region

15. Competition Landscape

    15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)

    15.2. Market Share Analysis, by Company (2023)

    15.3. Company Profiles

        15.3.1. Biocytogen Pharmaceuticals (Beijing) Co., Ltd.

            15.3.1.1. Company Overview

            15.3.1.2. Product Portfolio

            15.3.1.3. SWOT Analysis

            15.3.1.4. Financial Overview

            15.3.1.5. Strategic Overview

        15.3.2. Evotec A.G.

            15.3.2.1. Company Overview

            15.3.2.2. Product Portfolio

            15.3.2.3. SWOT Analysis

            15.3.2.4. Financial Overview

            15.3.2.5. Strategic Overview

        15.3.3. Sartorius AG

            15.3.3.1. Company Overview

            15.3.3.2. Product Portfolio

            15.3.3.3. SWOT Analysis

            15.3.3.4. Financial Overview

            15.3.3.5. Strategic Overview

        15.3.4. Charles River Laboratories International, Inc.

            15.3.4.1. Company Overview

            15.3.4.2. Product Portfolio

            15.3.4.3. SWOT Analysis

            15.3.4.4. Financial Overview

            15.3.4.5. Strategic Overview

        15.3.5. Creative Biolabs, Inc.

            15.3.5.1. Company Overview

            15.3.5.2. Product Portfolio

            15.3.5.3. SWOT Analysis

            15.3.5.4. Financial Overview

            15.3.5.5. Strategic Overview

        15.3.6. Bruker Cellular Analysis, Inc.

            15.3.6.1. Company Overview

            15.3.6.2. Product Portfolio

            15.3.6.3. SWOT Analysis

            15.3.6.4. Financial Overview

            15.3.6.5. Strategic Overview

        15.3.7. BioDuro LLC

            15.3.7.1. Company Overview

            15.3.7.2. Product Portfolio

            15.3.7.3. SWOT Analysis

            15.3.7.4. Financial Overview

            15.3.7.5. Strategic Overview

        15.3.8. Aragen Life Sciences

            15.3.8.1. Company Overview

            15.3.8.2. Product Portfolio

            15.3.8.3. SWOT Analysis

            15.3.8.4. Financial Overview

            15.3.8.5. Strategic Overview

        15.3.9. Abzena

            15.3.9.1. Company Overview

            15.3.9.2. Product Portfolio

            15.3.9.3. SWOT Analysis

            15.3.9.4. Financial Overview

            15.3.9.5. Strategic Overview

        15.3.10. AbTherx

            15.3.10.1. Company Overview

            15.3.10.2. Product Portfolio

            15.3.10.3. SWOT Analysis

            15.3.10.4. Financial Overview

            15.3.10.5. Strategic Overview

        15.3.11. Sanyou Biopharmaceuticals Co., Ltd.

            15.3.11.1. Company Overview

            15.3.11.2. Product Portfolio

            15.3.11.3. SWOT Analysis

            15.3.11.4. Financial Overview

            15.3.11.5. Strategic Overview

        15.3.12. Other Prominent Players

            15.3.12.1. Company Overview

            15.3.12.2. Product Portfolio

            15.3.12.3. SWOT Analysis

            15.3.12.4. Financial Overview

            15.3.12.5. Strategic Overview

List of Tables

Table 01: Global Antibody Discovery Market Size (US$ Bn) Forecast, by Antibody Type, 2020-2034

Table 02: Global Antibody Discovery Market Size (US$ Bn) Forecast, by Service, 2020-2034

Table 03: Global Antibody Discovery Market Size (US$ Bn) Forecast, by End-user, 2020-2034

Table 04: Global Antibody Discovery Market Size (US$ Bn) Forecast, by Region, 2020-2034

Table 05: North America Antibody Discovery Market Size (US$ Bn) Forecast, by Country, 2020-2034

Table 06: North America Antibody Discovery Market Size (US$ Bn) Forecast, by Antibody Type, 2020-2034

Table 07: North America Antibody Discovery Market Size (US$ Bn) Forecast, by Service, 2020-2034

Table 08: North America Antibody Discovery Market Size (US$ Bn) Forecast, by End-user, 2020-2034

Table 09: Europe Antibody Discovery Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034

Table 10: Europe Antibody Discovery Market Size (US$ Bn) Forecast, by Antibody Type, 2020-2034

Table 11: Europe Antibody Discovery Market Size (US$ Bn) Forecast, by Service, 2020-2034

Table 12: Europe Antibody Discovery Market Size (US$ Bn) Forecast, by End-user, 2020-2034

Table 13: Asia Pacific Antibody Discovery Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034

Table 14: Asia Pacific Antibody Discovery Market Size (US$ Bn) Forecast, by Antibody Type, 2020-2034

Table 15: Asia Pacific Antibody Discovery Market Size (US$ Bn) Forecast, by Service, 2020-2034

Table 16: Asia Pacific Antibody Discovery Market Size (US$ Bn) Forecast, by End-user, 2020-2034

Table 17: Latin America Antibody Discovery Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034

Table 18: Latin America Antibody Discovery Market Size (US$ Bn) Forecast, by Antibody Type, 2020-2034

Table 19: Latin America Antibody Discovery Market Size (US$ Bn) Forecast, by Service, 2020-2034

Table 20: Latin America Antibody Discovery Market Size (US$ Bn) Forecast, by End-user, 2020-2034

Table 21: Middle East & Africa Antibody Discovery Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034

Table 22: Middle East & Africa Antibody Discovery Market Size (US$ Bn) Forecast, by Antibody Type, 2020-2034

Table 23: Middle East & Africa Antibody Discovery Market Size (US$ Bn) Forecast, by Service, 2020-2034

Table 24: Middle East & Africa Antibody Discovery Market Size (US$ Bn) Forecast, by End-user, 2020-2034

List of Figures

Figure 01: Global Antibody Discovery Market Size (US$ Bn) and Distribution (%), by Region, 2023 and 2034

Figure 02: Global Antibody Discovery Market Revenue (US$ Bn), by Antibody Type, 2023

Figure 03: Global Antibody Discovery Market Value Share, by Antibody Type, 2023

Figure 04: Global Antibody Discovery Market Revenue (US$ Bn), by Service, 2023

Figure 05: Global Antibody Discovery Market Value Share, by Service, 2023

Figure 06: Global Antibody Discovery Market Revenue (US$ Bn), by End-user, 2023

Figure 07: Global Antibody Discovery Market Value Share, by End-user, 2023

Figure 08: Global Antibody Discovery Market Value Share, by Region, 2023

Figure 09: Global Antibody Discovery Market Value (US$ Bn) Forecast, 2020-2034

Figure 10: Global Antibody Discovery Market Value Share Analysis, by Antibody Type, 2023 and 2034

Figure 11: Global Antibody Discovery Market Attractiveness Analysis, by Region, 2024-2034

Figure 12: Global Antibody Discovery Market Value Share Analysis, by Service, 2023 and 2034

Figure 13: Global Antibody Discovery Market Attractiveness Analysis, by Service, 2024-2034

Figure 14: Antibody Discovery Market Value Share Analysis, by End-user, 2023 and 2034

Figure 15: Global Antibody Discovery Market Attractiveness Analysis, by End-user, 2024-2034

Figure 16: Global Antibody Discovery Market Value Share Analysis, by Region, 2023 and 2034

Figure 17: Global Antibody Discovery Market Attractiveness Analysis, by Region, 2024-2034

Figure 18: North America Antibody Discovery Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034

Figure 19: North America Antibody Discovery Market Attractiveness Analysis, by Country, 2024-2034

Figure 20: North America Antibody Discovery Market Value Share Analysis, by Country, 2023 and 2034

Figure 21: North America Antibody Discovery Market Value Share Analysis, by Antibody Type, 2023 and 2034

Figure 22: North America Antibody Discovery Market Value Share Analysis, by Service, 2023 and 2034

Figure 23: North America Antibody Discovery Market Value Share Analysis, by End-user, 2023 and 2034

Figure 24: North America Antibody Discovery Market Attractiveness Analysis, by Region, 2024-2034

Figure 25: North America Antibody Discovery Market Attractiveness Analysis, by Service, 2024-2034

Figure 26:North America Antibody Discovery Market Attractiveness Analysis, by End-user, 2024-2034

Figure 27: Europe Antibody Discovery Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034

Figure 28: Europe Antibody Discovery Market Attractiveness Analysis, by Country/Sub-region, 2024-2034

Figure 29: Europe Antibody Discovery Market Value Share Analysis, by Country/Sub-region, 2023 and 2034

Figure 30: Europe Antibody Discovery Market Value Share Analysis, by Antibody Type, 2023 and 2034

Figure 31: Europe Antibody Discovery Market Value Share Analysis, by Service, 2023 and 2034

Figure 32: Europe Antibody Discovery Market Value Share Analysis, by End-user, 2023 and 2034

Figure 33: Europe Antibody Discovery Market Attractiveness Analysis, by Region, 2024-2034

Figure 34: Europe Antibody Discovery Market Attractiveness Analysis, by Service, 2024-2034

Figure 35: Europe Antibody Discovery Market Attractiveness Analysis, by End-user, 2024-2034

Figure 36: Asia Pacific Antibody Discovery Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034

Figure 37: Asia Pacific Antibody Discovery Market Attractiveness Analysis, by Country/Sub-region, 2024-2034

Figure 38: Asia Pacific Antibody Discovery Market Value Share Analysis, by Country/Sub-region, 2023 and 2034

Figure 39: Asia Pacific Antibody Discovery Market Value Share Analysis, by Antibody Type, 2023 and 2034

Figure 40: Asia Pacific Antibody Discovery Market Value Share Analysis, by Service, 2023 and 2034

Figure 41: Asia Pacific Antibody Discovery Market Value Share Analysis, by End-user, 2023 and 2034

Figure 42: Asia Pacific Antibody Discovery Market Attractiveness Analysis, by Region, 2024-2034

Figure 43: Asia Pacific Antibody Discovery Market Attractiveness Analysis, by Service, 2024-2034

Figure 44: Asia Pacific Antibody Discovery Market Attractiveness Analysis, by End-user, 2024-2034

Figure 45: Latin America Antibody Discovery Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034

Figure 46: Latin America Antibody Discovery Market Attractiveness Analysis, by Country/Sub-region, 2024-2034

Figure 47: Latin America Antibody Discovery Market Value Share Analysis, by Country/Sub-region, 2023 and 2034

Figure 48: Latin America Antibody Discovery Market Value Share Analysis, by Antibody Type, 2023 and 2034

Figure 49: Latin America Antibody Discovery Market Value Share Analysis, by Service, 2023 and 2034

Figure 50: Latin America Antibody Discovery Market Value Share Analysis, by End-user, 2023 and 2034

Figure 51: Latin America Antibody Discovery Market Attractiveness Analysis, by Region, 2024-2034

Figure 52: Latin America Antibody Discovery Market Attractiveness Analysis, by Service, 2024-2034

Figure 53: Latin America Antibody Discovery Market Attractiveness Analysis, by End-user, 2024-2034

Figure 54: Middle East & Africa Antibody Discovery Market Size (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034

Figure 55: Middle East & Africa Antibody Discovery Market Attractiveness Analysis, by Country/Sub-region, 2024-2034

Figure 56: Middle East & Africa Antibody Discovery Market Value Share Analysis, by Country/Sub-region, 2023 and 2034

Figure 57: Middle East & Africa Antibody Discovery Market Value Share Analysis, by Antibody Type, 2023 and 2034

Figure 58: Middle East & Africa Antibody Discovery Market Value Share Analysis, by Service, 2023 and 2034

Figure 59: Middle East & Africa Antibody Discovery Market Value Share Analysis, by End-user, 2023 and 2034

Figure 60: Middle East & Africa Antibody Discovery Market Attractiveness Analysis, by Region, 2024-2034

Figure 61: Middle East & Africa Antibody Discovery Market Attractiveness Analysis, by Service, 2024-2034

Figure 62: Middle East & Africa Antibody Discovery Market Attractiveness Analysis, by End-user, 2024-2034

Copyright © Transparency Market Research, Inc. All Rights reserved